ハマダ　ヒロミチ   濱田　洋通    所属   その他 その他    職種   登録医
論文種別	原著
言語種別	英語
査読の有無	査読あり
表題	Sivelestat Sodium Hydrate Treatment for refractory Kawasaki Disease Patients.
掲載誌名	正式名：Pediatrics international : official journal of the Japan Pediatric Society 略　 称：Pediatr Int ISSNコード：(1442-200X)1328-8067(Linking)
掲載区分	国外
巻・号・頁	61(5),pp.438-443
著者・共著者	EBATA Ryota†*, YASUKAWA Kumi, NAGAI Kazue, SAITO Yuko, HIGASHI Kouji, HOMMA Jun, TAKADA Nobuyuki, TAKECHI Fumie, SAITO Naoki, KOBAYASHI Hironobu, OKUNUSHI Kentaro, HAMADA Hiromichi, KOHNO Yoichi, HANAOKA Hideki, SHIMOJO Naoki
発行年月	2019/05
概要	Additional IVIG combined with SSH as a second-line therapy for KD patients who were refractory to initial IVIG therapy was safe and well tolerated and could be a promising option for severe KD patients. Further investigations are expected to clarify safety and timing of SSH treatment for patients with KD. This article is protected by copyright. All rights reserved.
DOI	10.1111/ped.13851
PMID	30916859